Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Reznik

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
European Journal of Endocrinology|March 26, 2008
Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinomaStéphane Bardet, Elodie Malville, Jean-Pierre Rame, et al.
Diabetes, Obesity & Metabolism|April 5, 2017
Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trialMuriel Metzger, Javier Castañeda, Yves Reznik, et al.
Annales D'Endocrinologie|December 8, 2020
Adherence to growth hormone therapy guidelines in a real-world French cohort of adult patients with growth hormone deficiencyFrançoise Borson-Chazot, Olivier Chabre, Sylvie Salenave, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 1, 2022
Sensor-Augmented Insulin Pump with Predictive Low-Glucose Suspend (PLGS): Determining Optimal Settings of Pump and Sensor in a Multicenter Cohort of Patients with Type 1 DiabetesMichael Joubert, Anaïs R Briant, Laurence Kessler, et al.
Journal of Diabetes Science and Technology|December 10, 2021
Needle Technology for Insulin Administration: A Century of InnovationLutz Heinemann, Trung Nguyen, Timothy S Bailey, et al.
Diabetes Technology & Therapeutics|August 5, 2015
The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise StudyIgnacio Conget, Javier Castaneda, Goran Petrovski, et al.
Journal of Diabetes Science and Technology|August 1, 2014
Accuracy of a new patch pump based on a microelectromechanical system (MEMS) compared to other commercially available insulin pumps: results of the first in vitro and in vivo studiesSophie Borot, Sylvia Franc, Justine Cristante, et al.
Endocrine|October 5, 2019
<sup>68</sup>Ga-DOTATOC PET/CT in detecting neuroendocrine tumours responsible for initial or recurrent paraneoplastic Cushing's syndromeOphélie Bélissant Benesty, Valérie Nataf, Jessica Ohnona, et al.
The Journal of Clinical Endocrinology and Metabolism|February 12, 2005
Abnormal sensitivity of cortisol-producing adrenocortical adenomas to serotonin: in vivo and in vitro studiesVincent Contesse, Yves Reznik, Estelle Louiset, et al.
Diabetes Technology & Therapeutics|February 13, 2024
Assessment of the Impact of Subcutaneous Catheter Change on Glucose Control in Patients with Type 1 Diabetes Treated by Insulin Pump in Open- and Closed-Loop ModesJean-Baptiste Julla, Pauline Jacquemier, Elisabeth Bonnemaison, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
European Journal of Endocrinology|March 26, 2008
Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinomaStéphane Bardet, Elodie Malville, Jean-Pierre Rame, et al.
Diabetes, Obesity & Metabolism|April 5, 2017
Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trialMuriel Metzger, Javier Castañeda, Yves Reznik, et al.
Annales D'Endocrinologie|December 8, 2020
Adherence to growth hormone therapy guidelines in a real-world French cohort of adult patients with growth hormone deficiencyFrançoise Borson-Chazot, Olivier Chabre, Sylvie Salenave, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 1, 2022
Sensor-Augmented Insulin Pump with Predictive Low-Glucose Suspend (PLGS): Determining Optimal Settings of Pump and Sensor in a Multicenter Cohort of Patients with Type 1 DiabetesMichael Joubert, Anaïs R Briant, Laurence Kessler, et al.
Journal of Diabetes Science and Technology|December 10, 2021
Needle Technology for Insulin Administration: A Century of InnovationLutz Heinemann, Trung Nguyen, Timothy S Bailey, et al.
Diabetes Technology & Therapeutics|August 5, 2015
The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise StudyIgnacio Conget, Javier Castaneda, Goran Petrovski, et al.
Journal of Diabetes Science and Technology|August 1, 2014
Accuracy of a new patch pump based on a microelectromechanical system (MEMS) compared to other commercially available insulin pumps: results of the first in vitro and in vivo studiesSophie Borot, Sylvia Franc, Justine Cristante, et al.
Endocrine|October 5, 2019
<sup>68</sup>Ga-DOTATOC PET/CT in detecting neuroendocrine tumours responsible for initial or recurrent paraneoplastic Cushing's syndromeOphélie Bélissant Benesty, Valérie Nataf, Jessica Ohnona, et al.
The Journal of Clinical Endocrinology and Metabolism|February 12, 2005
Abnormal sensitivity of cortisol-producing adrenocortical adenomas to serotonin: in vivo and in vitro studiesVincent Contesse, Yves Reznik, Estelle Louiset, et al.
Diabetes Technology & Therapeutics|February 13, 2024
Assessment of the Impact of Subcutaneous Catheter Change on Glucose Control in Patients with Type 1 Diabetes Treated by Insulin Pump in Open- and Closed-Loop ModesJean-Baptiste Julla, Pauline Jacquemier, Elisabeth Bonnemaison, et al.
Pageof 14